Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cristina M Quintella, Heitor M Quintella, Mayla Rohweder & Guilherme M Quintella. (2020) Advances in patent applications related to cancer vaccine using CpG-ODN and OX40 association. Expert Opinion on Therapeutic Patents 30:4, pages 287-301.
Read now
Read now
Kislay Roy, Rupinder K Kanwar, Subramanian Krishnakumar, Chun Hei Antonio Cheung & Jagat R Kanwar. (2015) Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model. International Journal of Nanomedicine 10, pages 1019-1043.
Read now
Read now
Jagat R. Kanwar, Kislay Roy & Rupinder K. Kanwar. (2011) Chimeric aptamers in cancer cell-targeted drug delivery. Critical Reviews in Biochemistry and Molecular Biology 46:6, pages 459-477.
Read now
Read now
Articles from other publishers (35)
Dariimaa Ganbat, Bat-Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Ambaga Miyegombo, Gantsetseg Garmaa, Yoshihisa Takahashi, Ryuji Fukuzawa, Ichiro Mori, Takayuki Shiomi, Akinori Nakata & Yasuhiko Tomita. (2022) Use of the Naphthoquinone YM155 (Sepantronium Bromide) in the Treatment of Cancer: A Systematic Review and Meta-Synthesis. Oncologie 24:2, pages 195-225.
Crossref
Crossref
Man-Yu Chu, He-Cheng Huang, En-Ming Li & Li-Yan Xu. (2021) CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy. Current Medicinal Chemistry 28:19, pages 3787-3802.
Crossref
Crossref
Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani & Mohammad Tariq Malik. (2021) AS1411-functionalized delivery nanosystems for targeted cancer therapy. Exploration of Medicine.
Crossref
Crossref
Sadia Ata, Atta Rasool, Atif Islam, Ismat Bibi, Muhammad Rizwan, Muhammad Khalid Azeem, Anees ur Rehman Qureshi & Munawar Iqbal. (2019) Loading of Cefixime to pH sensitive chitosan based hydrogel and investigation of controlled release kinetics. International Journal of Biological Macromolecules.
Crossref
Crossref
Min Xiao, Yi Xue, Zhongzhi Wu, Zi-Ning Lei, Jin Wang, Zhe-Sheng Chen & Wei Li. (2019) Design, synthesis and biological evaluation of selective survivin inhibitors. The Journal of Biomedical Research 33:2, pages 82.
Crossref
Crossref
Katarzyna Ratajczak, Bartlomiej E. Krazinski, Anna E. Kowalczyk, Beata Dworakowska, Slawomir Jakiela & Magdalena Stobiecka. (2018) Hairpin–Hairpin Molecular Beacon Interactions for Detection of Survivin mRNA in Malignant SW480 Cells. ACS Applied Materials & Interfaces 10:20, pages 17028-17039.
Crossref
Crossref
Fan Zhang, Jinjin Chu & Fan Wang. (2017) Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas. Oncology Letters 14:2, pages 1303-1308.
Crossref
Crossref
Eman Alaaeldin, Amr S. Abu Lila, Hidenori Ando, Masakazu Fukushima, Cheng-Long Huang, Hiromi Wada, Hatem A. Sarhan, Khaled A. Khaled & Tatsuhiro Ishida. (2017) Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules. Journal of Controlled Release 255, pages 210-217.
Crossref
Crossref
Majid Zaki Dizaji, Seyed H Ghaffari, Elham Hosseini, Nasrin Alizadeh, Shahrbano Rostami, Majid Momeny, Kamran Alimoghaddam & Ardeshir Ghavamzadeh. (2017) Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α. Asia-Pacific Journal of Clinical Oncology 13:2, pages e21-e30.
Crossref
Crossref
Jaisy Samuel, Rupinder K. Kanwar, Jagat R. Kanwar, Vikas Khetan & Subramanian Krishnakumar. (2016) A Study of Gene Expression of Survivin, its Antiapoptotic Variants, and Targeting Survivin In Vitro for Therapy in Retinoblastoma. Journal of Pediatric Hematology/Oncology 38:7, pages e230-e242.
Crossref
Crossref
Wei Dai, Quangen Gao, Jianping Qiu, Jianmao Yuan, Guoliang Wu & Genhai Shen. (2015) Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. Tumor Biology 37:5, pages 6307-6313.
Crossref
Crossref
YINGZHE PAN, YIQIAO XING & HUI WANG. (2015) Expression of survivin in adenoid cystic carcinoma of the lacrimal gland and the effect of intervention with arsenic trioxide in vitro. Experimental and Therapeutic Medicine 10:1, pages 330-334.
Crossref
Crossref
Yugang LiuZhaowei TengYing WangPengfei GaoJunli Chen. (2015) Prognostic Significance of Survivin Expression in Osteosarcoma Patients: A Meta-Analysis. Medical Science Monitor 21, pages 2877-2885.
Crossref
Crossref
Nithya Subramanian, Jagat R. Kanwar, Balachandran Akilandeswari, Rupinder K. Kanwar, Vikas Khetan & Subramanian Krishnakumar. (2015) Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery. Chemical Communications 51:32, pages 6940-6943.
Crossref
Crossref
LI ZHANG, YOUYOU YE, DEJIAN YANG & JIANHUA LIN. (2014) Survivin and vascular endothelial growth factor are associated with spontaneous pulmonary metastasis of osteosarcoma: Development of an orthotopic mouse model. Oncology Letters 8:6, pages 2577-2580.
Crossref
Crossref
Zhao-Shi Bao, Ming-Yang Li, Jia-Yin Wang, Chuan-Bao Zhang, Hong-Jun Wang, Wei Yan, Yan-Wei Liu, Wei Zhang, Ling Chen & Tao Jiang. (2014) Prognostic Value of a Nine-Gene Signature in Glioma Patients Based on mRNA Expression Profiling. CNS Neuroscience & Therapeutics 20:2, pages 112-118.
Crossref
Crossref
Huan-qin Wang, Jian-jun Jin & Jing Wang. (2014) Arctigenin Enhances Chemosensitivity to Cisplatin in Human Nonsmall Lung Cancer H460 Cells through Downregulation of Survivin Expression. Journal of Biochemical and Molecular Toxicology 28:1, pages 39-45.
Crossref
Crossref
Lu Cao, Chunguang Li, Shuwen Shen, Yan Yan, Weidan Ji, Jinghan Wang, Haihua Qian, Xiaoqing Jiang, Zhigang Li, Mengchao Wu, Ying Zhang & Changqing Su. (2013) OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer 13:1.
Crossref
Crossref
Swati Dawar, Neha Singh, Rupinder K. Kanwar, Richard Lee Kennedy, Rakesh N. Veedu, Shu-Feng Zhou, Subramanian Krishnakumar, Sarbani Hazra, Sreenivasan Sasidharan, Wei Duan & Jagat R. Kanwar. (2013) Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers. Drug Discovery Today 18:23-24, pages 1292-1300.
Crossref
Crossref
Zhengyu Li, Wenjiao Min & Jinhai Gou. (2013) Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways. Cancer Chemotherapy and Pharmacology 72:5, pages 1001-1011.
Crossref
Crossref
Jian Song, Hong Su, Yang-yang Zhou & Liang-liang Guo. (2013) Prognostic value of survivin expression in breast cancer patients: a meta-analysis. Tumor Biology 34:4, pages 2053-2062.
Crossref
Crossref
Jagat R. Kanwar, Sishir K. Kamalapuram & Rupinder K. Kanwar. (2013) Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Medicinal Research Reviews 33:4, pages 765-789.
Crossref
Crossref
Beom Seob LeeSoo Hyuk KimTaewon JinEun Young ChoiJaewon OhSungha ParkSang Hak LeeJi Hyung ChungSeok-Min Kang. (2013) Protective Effect of Survivin in Doxorubicin-Induced Cell Death in H9c2 Cardiac Myocytes. Korean Circulation Journal 43:6, pages 400.
Crossref
Crossref
Chin-Sheng Hung, Shen-Fu Lin, Hui-Hsiung Liu, Li-Jen Kuo, Li-Tzu Li, Hou-Yu Su, Phui-Ly Liew, Feng-Yen Lin, Po-Li Wei, Der-Zen Liu & Yu-Jia Chang. (2012) Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma. Annals of Surgical Oncology 19:8, pages 2744-2752.
Crossref
Crossref
XIANG-QI CHEN, SHENG YANG, MING-QIANG KANG, ZHI-YING LI, HUI-SHAN LU & TING-YAN LIN. (2012) Survivin expression in human lung cancer and the influence of its downregulation on the biological behavior of human lung cancer cells. Experimental and Therapeutic Medicine 3:6, pages 1010-1014.
Crossref
Crossref
Chi-Tai Yeh, Yerra Koteswara Rao, Min Ye, Wen-Shi Wu, Tung-Chen Chang, Liang-Shun Wang, Chih-Hsiung Wu, Alexander T.H. Wu & Yew-Min Tzeng. (2012) Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Toxicology and Applied Pharmacology 261:1, pages 31-41.
Crossref
Crossref
Young Il Kim, Byeong-Cheol Ahn, John A. Ronald, Regina Katzenberg, Abhinav Singh, Ramasamy Paulmurugan, Sunetra Ray, Sanjiv S. Gambhir & Lawrence V. Hofmann. (2012) Intratumoral versus Intravenous Gene Therapy Using a Transcriptionally Targeted Viral Vector in an Orthotopic Hepatocellular Carcinoma Rat Model. Journal of Vascular and Interventional Radiology 23:5, pages 704-711.
Crossref
Crossref
Xiao‐Yuan Chu, Long‐Bang Chen, Jing‐Hua Wang, Quan‐Sheng Su, Ji‐Rong Yang, Yong Lin, Li‐Jun Xue, Xiao‐Bei Liu & Xiao‐Bei Mo. (2011) Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer. Journal of Surgical Oncology 105:6, pages 520-528.
Crossref
Crossref
Meena Upadhyaya, Gill Spurlock, Laura Thomas, Nick S. T. Thomas, Mark Richards, Viktor-Felix Mautner, David N. Cooper, Abhijit Guha & Jim Yan. (2012) Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis. Human Mutation 33:4, pages 763-776.
Crossref
Crossref
Tomoko Kurita, Hiroto Izumi, Seiji Kagami, Toshinori Kawagoe, Naoyuki Toki, Yusuke Matsuura, Toru Hachisuga & Kimitoshi Kohno. (2012) Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer. Cancer Science 103:2, pages 239-444.
Crossref
Crossref
Jiamu Du, Alexander E. Kelly, Hironori Funabiki & Dinshaw J. Patel. (2012) Structural Basis for Recognition of H3T3ph and Smac/DIABLO N-terminal Peptides by Human Survivin. Structure 20:1, pages 185-195.
Crossref
Crossref
C. Di Cresce, R. Figueredo, P. J. Ferguson, M. D. Vincent & J. Koropatnick. (2011) Combining Small Interfering RNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to 5-Fluorodeoxyuridine and Pemetrexed. Journal of Pharmacology and Experimental Therapeutics 338:3, pages 952-963.
Crossref
Crossref
Eugene ParkEun Ji GangYao-Te HsiehPaul SchaeferSanna ChaeLars Klemm, Sandra HuantesMignon LohEdward M. ConwayEun-Suk Kang, Hong Hoe KooWolf-Karsten HofmannNora HeisterkampLouis PelusGanesan Keerthivasan, John Crispino, Michael Kahn, Markus Müschen & Yong-Mi Kim. (2011) Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood 118:8, pages 2191-2199.
Crossref
Crossref
Jagat R. Kanwar, Sishir K. Kamalapuram & Rupinder K. Kanwar. (2011) Targeting survivin in cancer: the cell-signalling perspective. Drug Discovery Today 16:11-12, pages 485-494.
Crossref
Crossref
Jagat R. Kanwar, Ganesh Mahidhara & Rupinder K. Kanwar. (2011) Antiangiogenic therapy using nanotechnological-based delivery system. Drug Discovery Today 16:5-6, pages 188-202.
Crossref
Crossref